Organization · Venture Capital
Intrinsic Capital Partners
Intrinsic Capital Partners is a Pennsylvania-based investment firm specializing in the legal cannabinoid market, focusing on life science and technology businesses. The firm emphasizes innovative solutions that enhance healthcare delivery and patient outcomes.
Overview
What Intrinsic Capital Partners does
What Intrinsic Capital Partners is
Intrinsic Capital Partners is a Pennsylvania-based investment firm specializing in the legal cannabinoid market, focusing on life science and technology businesses. The firm emphasizes innovative solutions that enhance healthcare delivery and patient outcomes.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2018
- Approximate age
- About 8 years
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find Intrinsic Capital Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Intrinsic Capital Partners as a funder
Investment thesis
Intrinsic Capital Partners focuses on the legal cannabinoid supply chain, investing in labs, software, consumer products, pharma, and production technology. The firm leverages an operating advisor network with expertise in healthcare, technology, consumer marketing, and regulatory affairs.
Focus narrative
Intrinsic Capital Partners invests in healthcare companies, particularly those involved in the legal cannabinoid sector. The firm is dedicated to identifying and supporting innovative technologies and solutions that can transform patient care and healthcare delivery.
Value beyond capital
Intrinsic Capital Partners adds value to its portfolio companies through a robust network of operating advisors with deep expertise in healthcare, technology, consumer marketing, and regulatory affairs. This support helps portfolio companies navigate challenges and seize opportunities in the evolving cannabis market.
Focus and fit
- Stages
- Growth Equity
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 6
Portfolio context
ACT Laboratories: Provides cannabis/hemp lab testing services. Treez: Offers business management software tailored for the cannabis industry. Hound Labs: Develops breathalyzer technology for detecting marijuana and alcohol. Elemental Brands: Focuses on hemp-derived consumer healthcare products. Biopharmaceutical Research Company: Engaged in botanical cannabis pharmaceuticals, led a $20M Series A. Nalu Bio: Specializes in chemistry-based cannabinoid production, participated in a venture round.
Common questions
What to know about Intrinsic Capital Partners
Upseed classifies Intrinsic Capital Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.